Patent · US Active

α4β7 thioether peptide dimer antagonists

US11840581B2 · kind B2 · utility

0Cited by

44References

17Claims

0Family size

Assignee

Protagonist Therapeutics, Inc. · US

Inventors

Ashok Bhandari · Pleasanton, US
Dinesh V. Patel · Fremont, US
Genet Zemede · San Jose, US
Brian Troy Frederick · Arlanza, US
Larry C. Mattheakis · Cupertino, US
David Liu · Palo Alto, US

Key dates

Filing date	Dec 29, 2020
Grant date	Dec 12, 2023
Priority date	—
Expiry date	Dec 29, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.